Journal Mobile Options
Table of Contents
Vol. 34, No. 1, 2001
Issue release date: January–February 2001
Psychopathology 2001;34:23–28

Clinical Subtypes of Schizophrenic Disorders: A Cluster Analytic Study

Lykouras L. · Oulis P. · Daskalopoulou E. · Psarros K. · Christodoulou G.N.
Department of Psychiatry, Schizophrenia Research Program, University of Athens, Eginition Hospital, Athens, Greece

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Two hundred and fifty-five psychiatric inpatients with a definite diagnosis of DSM-IV schizophrenic disorder were examined by means of the Structured Clinical Interview and rated on the 30 main items of the Positive and Negative Syndrome Scale (PANSS). Patients’ scores were subjected to a cluster analysis, using Ward’s method. Cluster analysis indicated the existence of five groups. The first group (n = 46) comprised patients with overall psychopathology of minimal severity, the second group (n = 39) patients with severe positive symptoms along with symptoms of psychomotor excitement, the third group (n = 58) patients with severe positive psychopathology only, the fourth group (n = 34) patients with severe positive negative depressive and cognitive symptoms and, finally, the fifth group (n = 78) patients with severe negative symptoms only. Patients in the first and third groups were older and their illnesses were of longer duration compared to those of the remaining groups. With respect to DSM-IV clinical types of schizophrenic disorders, the paranoid type predominated in the second and the third groups, whereas the disorganized and catatonic types were markedly overpresented in the fifth group.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Crow TJ: Molecular pathology of schizophrenia: More than one disease process? Br Med J 1980;260:66–68.
  2. Andreasen NC: Negative syndroms in schizophrenia. Arch Gen Psychiatry 1982;39:784.
  3. Lépine JP: Dimensions positives et négatives dans les schizophrenies. Cahiers Prisme 1991;1:23–29.
  4. Dollfus S, Petit M, Lesieur P, Menard JP: Principal component analysis of PANSS and SANS-SAPS global ratings in schizophrenic patients. Eur Psychiatry 1991;6:251–259.
  5. Lindstrom E, Von Knorring L: Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for Schizophrenia. Nord J Psychiatry 1993;47:257–263.
  6. Bell MD, Lysaker PH, Beam-Goulet JL, Milstein RM, Lindenmayer JP: Five-component model of schizophrenia: Assessing the factorial invariance of the Positive and Negative Syndrome Scale. Psychiatry Res 1994;52:295–303.
  7. Lindenmayer JP, Bernstein-Hyman R, Grochowski BA: Five-factor model of schizophrenia. Initial validation. J Nerv Ment Dis 1994;182:631–638.
  8. Lancon C, Aghababian V, Leorca PM, Auquier P: Factorial structure of the positive and negative syndrome scale (PANSS): A forced five-dimensional factor analysis. Acta Psychiatr Scand 1998;97:369–376.
  9. Everitt BS (ed): Cluster Analysis. London, Arnold, 1993.
  10. Bartko JJ, Carpenter WT, Strauss JS: Statistical basis for exploring schizophrenia. Am J Psychiatry 1981;138:941–947.

    External Resources

  11. Farmer AE, McGuffin P, Spitznagel EL: Heterogeneity in schizophrenia: A cluster-analytic approach. Psychiatry Res 1982;8:1–12.

    External Resources

  12. Morrison RL, Bellack A, Wixted JT, Mueser KT: Positive and negative symptoms in schizophrenia: A cluster analytic approach. J Nerv Ment Dis 1990;178:377–384.
  13. Dollfus S, Everitt B, Ribeyre JM, Assouly-Besse F, Sharp C, Petit M: Identifying subtypes of schizophrenia by cluster analysis. Schizophr Bull 1996;22:245–555.
  14. Goldman M, Tandon R, Decker L: Cluster analysis: A useful tool for identifying homogenous subtypes of schizophrenia. American Psychiatric Association, Annual Meeting, May 1997, Program and Abstract, p 16.
  15. Kay SR, Opler LA, Fiszbein A (eds): Positive and Negative Syndrome Scale (PANSS) Rating Manual. San Raphael, Social and Behavioral Science Documents, 1987.
  16. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 rev. Washington, APA, 1987.
  17. Spitzer R, Williams JB: Structural Clinical Interview for DSM-IIIR. New York, Psychiatric Institute, 1985.
  18. Lykouras L, Botsis A, Oulis P (eds): The Greek Version of Positive and Negative Syndrome Scale. Standardization and Validation. Athens, Tsiveriotis, 1997.
  19. Andreasen N, Endicott J, Spitzer R, Winokur G: The family history method using diagnostic criteria: Reliability and validity. Arch Gen Psychiatry 1997;34:1229–1235.
  20. Everitt BS (ed): Statistical Methods in Medical Investigations, ed 2. London, Arnold, 1994, p. 149.
  21. Strauss JS, Carpenter WT Jr, Bartko JJ: The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1974;11:61–69.

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50